(Q42740250)

6 November 2017

Effect of resveratrol on platelet activation in hypercholesterolemic rats: CD40-CD40L system as a potential target (English)

1 reference

6 November 2017

0 references

Ayşe Yeşim Göçmen

1

1 reference

PubMed ID

21574786

6 November 2017

Durmus Burgucu

series ordinal

2

1 reference

PubMed ID

21574786

6 November 2017

Saadet Gümüşlü

series ordinal

3

1 reference

6 November 2017

16 May 2011

1 reference

Applied Physiology, Nutrition, and Metabolism

6 November 2017

1 reference

6 November 2017

36

1 reference

6 November 2017

3

1 reference

6 November 2017

323-330

1 reference

Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation

6 November 2017

1 reference

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

21 January 2018

1 reference

Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent

21 January 2018

1 reference

Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation

21 January 2018

1 reference

Low-density lipoprotein-lowering medication and platelet function

21 January 2018

1 reference

Biological effects of resveratrol

21 January 2018

1 reference

Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia

21 January 2018

1 reference

Effect of atorvastatin on the expression of CD40 ligand and P-selectin on platelets in patients with hypercholesterolemia

21 January 2018

1 reference

CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.

21 January 2018

1 reference

Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC.

21 January 2018

1 reference

Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion

21 January 2018

1 reference

Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry

21 January 2018

1 reference

The relative role of PLCbeta and PI3Kgamma in platelet activation

21 January 2018

1 reference

Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention

21 January 2018

1 reference

Mechanisms of resveratrol-induced platelet apoptosis.

21 January 2018

1 reference

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

21 January 2018

1 reference

Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats

21 January 2018

1 reference

Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation.

21 January 2018

1 reference

Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors

21 January 2018

1 reference

Apo A-I binding to platelets detected by flow cytometry

21 January 2018

1 reference

Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat

21 January 2018

1 reference

Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system

21 January 2018

1 reference

Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters

21 January 2018

1 reference

CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease

21 January 2018

1 reference

CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation

21 January 2018

1 reference

Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits

21 January 2018

1 reference

Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/H11-022

1 reference

6 November 2017

1 reference

PubMed ID

21574786